logo

For the Inventor, By the Inventor

Westborough, MA, United States of America

Astellas Institute for Regenerative Medicine


USPTO Granted Patents = 36



Trademarks = 2

Forward Citations = 185

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Robert P Lanza (26 out of 55 patents)

silverMedal Shi-Jiang Lu (15 out of 19 patents)

bronzeMedal Irina V Klimanskaya (9 out of 24 patents)

4.  Qiang Feng (7 out of 7 patents)

5.  Roger Gay (6 out of 6 patents)

6.  Young Gie Chung (4 out of 13 patents)

7.  William K Holmes (3 out of 63 patents)

8.  Wei Wang (3 out of 3 patents)

9.  Judson Ratliff (3 out of 3 patents)

10.  Romma E Southwick (3 out of 3 patents)

11.  Linda Lemieux (3 out of 3 patents)

12.  Christopher Malcuit (3 out of 3 patents)

13.  Pedro Huertas (3 out of 3 patents)

14.  Lucy Vilner (3 out of 3 patents)

15.  Erin Anne Kimbrel (3 out of 5 patents)


36 patents:

1. 12508284 - Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells (2025-12-30),
2. 12465621 - Mesenchymal stromal cells and uses related thereto (2025-11-11),
3. 12419958 - Clinical formulations (2025-09-23),
4. 12209255 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2025-01-28),
5. 12109239 - Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof (2024-10-08),
6. 12097223 - Mesenchymal stromal cells and uses related thereto (2024-09-24),
7. 12076347 - Methods for production of platelets from pluripotent stem cells and compositions thereof (2024-09-03),
8. 12049642 - Corneal endothelial cells with increased cell density and compositions thereof (2024-07-30),
9. 11957754 - Clinical formulations (2024-04-16),
10. 11850261 - Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells (2023-12-26),
11. 11739366 - Methods for detection of rare subpopulations of cells and highly purified compositions of cells (2023-08-29),
12. 11680941 - Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors (2023-06-20),
13. 11566228 - Hemangio-colony forming cells (2023-01-31),
14. 11422125 - Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors (2022-08-23),
15. 11400118 - Methods for production of platelets from pluripotent stem cells and compositions thereof (2022-08-02),
Astellas Institute for Regenerative Medicine (AIRM) is a subsidiary of Astellas Pharma, Inc. It is a biotechnology company focused on the development of innovative therapies leveraging stem cell technologies. AIRM is dedicated to advancing the field of regenerative medicine through research, development, and commercialization of novel stem cell-based therapies to address unmet medical needs.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

...
36 Patents

#8 in Westborough, MA

#539 in Massachusetts

#9,198 in US

#18,193 in the World

...
Westborough, MA, United States of America

Astellas Institute for Regenerative Medicine

Forward Citations = 185

23 inventors:

goldMedal Robert P Lanza (26 out of 55 patents)

silverMedal Shi-Jiang Lu (15 out of 19 patents)

bronzeMedal Irina V Klimanskaya (9 out of 24 patents)

4.  Qiang Feng (7 out of 7 patents)

5.  Roger Gay (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com
Loading…